3 files

Neonatal Pertussis, an Under-Recognized Health Burden and Rationale for Maternal Immunization: A Systematic Review of South and South-East Asian Countries

posted on 30.04.2019 by Ashish Agrawal, Sanjeev Singh, Shafi Kolhapure, Walid Kandeil, Rishma Pai, Tanu Singhal

Full copyright for enhanced digital features is owned by GlaxoSmithKline Biologicals SA.

As well as a summary slide, this page also contains the following digital features:

Feature 1 Plain Language Summary - Focus on the Patient

Feature 1 highlights the context of the article, the importance of neonatal pertussis, maternal immunization and steps that should be taken in the future to address the impact of neonatal pertussis disease burden.

Feature 2 Transfer of Maternal Antibodies and Window of Vulnerability in Infants

Panel 1 demonstrates the physiological changes during the pregnancy period in unvaccinated mothers which would leave the newborn vulnerable to disease.

Panel 2 shows that vaccinated mothers confer protection to the newborn through the mechanism of maternal–fetal-antibody transfer.

Source: Adapted from Jones C, Heath P. Antenatal immunization. Hum Vaccin Immunother. 2014;10:2118-22.

Provide enhanced digital features for this article
If you are an author of this publication and would like to provide additional enhanced digital features for your article then please contact adisrapidplus@springer.com.

The journal offers a range of additional features designed to increase visibility and readership. All features will be thoroughly peer reviewed to ensure the content is of the highest scientific standard and all features are marked as ‘peer reviewed’ to ensure readers are aware that the content has been reviewed to the same level as the articles they are being presented alongside. Moreover, all sponsorship and disclosure information is included to provide complete transparency and adherence to good publication practices. This ensures that however the content is reached the reader has a full understanding of its origin. No fees are charged for hosting additional open access content.

Other enhanced features include, but are not limited to:
• Slide decks
• Videos and animations
• Audio abstracts
• Audio slides


GlaxoSmithKline Biologicals SA